RhoGEF12 regulates endosomal SORL1-retromer and its inhibition is therapeutic in human neuronal models of Alzheimer's disease
Yasir H. Qureshi, Charles A. Williams, István Hajdú, Suvarnambiga Kannan, Ananya Govindarajan, Barbara M. Végh, Gregory A. Petsko, Jessica E. Young, Péter Závodszky, Scott A. Small
Pharmacological inhibition of RhoGEF12 increases endosomal SORL1-retromer recycling and reduces pathogenic amyloid secretion in human neuronal models, identifying a novel, targetable pathway for treating Alzheimer's disease.
bioRxiv · Mar 9, 2026 · PreprintNeuroscience